Duan et al. (2018) proved that sulfasalazine inhibited M1 polarization of microglia and release of inflammatory factors by inhibiting HOTAIR expression, promoting myelin regeneration. This suggests that inhibition of HOTAIR expression is a potential approach in the treatment of MS (Duan et al., 2018). This evidence concerns the gene HOTAIR and myeloid sarcoma.